DIA
Drug Information Association Logo
« Back to Listing

Nesting Studies Within Patient Registries to Support Comparative Effectiveness Research

Track:
Comparative Effectiveness Research/Global Health Outcomes and Economics

Day & Time:
June 18, 1:30PM - 3:00PM (Pacific Standard Time)

Session Number:
369

Room Number:
17A

Level:
Intermediate

Type:
Workshop

Title:
Nesting Studies Within Patient Registries to Support Comparative Effectiveness Research

Chair(s):
Nancy A. Dreyer, PhD, MPH, FISPE
Global Chief of Scientific Affairs, Real-World and Late Phase Research
Quintiles Realworld & Late Phase Research, United States

Description:
Nesting studies within patient registries can be an efficient use of existing registry resources. This workshop will examine design and operational considerations for nested studies and present examples of nested studies used to support comparative effectiveness research.

**Due to workshop format, seating will be limited and will be available on a first come, first served basis.

The San Diego Convention Center has stringent regulations on maximum room capacities, and they are strictly enforced. Once all seats are occupied, DIA will be required to close the workshop, and no more participants will be admitted. Interested attendees are encouraged to arrive at workshops early in order to ensure seating. Please note, as a workshop with interactivity, this offering will not be recorded.

Learning Objective(s):
Discuss the strengths and limitations of nesting studies within registries; Identify key considerations for designing, operating, and analyzing a nested study, including selecting an appropriate registry, recruiting participants, managing informed consent, and ensuring data security; Describe current uses of nested registry studies for research on effectiveness and outcomes.

Presentation(s) & Speaker(s):
Facilitator
Stella Blackburn
Vice President, Global Head of RIsk Management
Quintiles., United Kingdom

Nesting Studies in Registries to Support Comparative Effectiveness Research: An Industry Perspective
Kathy L Lampl, MD
Medical Director, Immunology and Infectious Diseases
Genentech, A Member of the Roche Group, United States